🌱 💊 We are excited to share this insightful article which explores the challenges of eco-friendly contract manufacturing for the pharmaceutical industry, this article covers Supply Chain Resilience and Optimisation, The Cost-Value Conundrum, Reducing Regulatory and Political Risk and many more challenges that face CDMOs & Pharma companies. #Sustainability #cdmo #pharma #greenpharma
Lab to Lead’s Post
More Relevant Posts
-
When bringing a drug product to market, there are several factors that need to be considered to gain competitive advantage. Tom Hegarty, Director - Operations – Manufacturing at Almac Pharma Services sat down with Pharmaceutical Outsourcing Magazine to discuss the key motivators and how service providers are adapting their offerings to meet this challenge. Read more: https://hubs.li/Q02PhFKd0
-
-
When bringing a drug product to market, there are several factors that need to be considered to gain competitive advantage. Tom Hegarty, Director - Operations – Manufacturing at Almac Pharma Services, sat down with Pharmaceutical Outsourcing Magazine to discuss the key motivators and how service providers are adapting their offerings to meet this challenge. Read more: https://hubs.li/Q02P6Yf80
-
-
Two days until the highly anticipated CiPPPA webinar. Meet the industry experts leading the discussion on circularity within primary pharmaceutical packaging. Remember to register and join the conversation: https://bit.ly/4bBI4Uz Michele Langford-Dropmann Merck Group Harriet Lewis Chiesi Group Joseph Muscat Haleon Eli Lilly and Company Ryan Stolzenbach AbbVie #CiPPPA #pharmaceuticalindustry #sustainablepackaging #circulareconomy #webinar #pharmapackaging
-
No. 1 Pharma news weekly in the South Asian markets of India, Bangladesh, Pakistan, Nepal and Sri Lanka.
Need to revolutionize pharma packaging to meet industry demands through cutting─edge innovations: Experts https://lnkd.in/gBPtYgaP There is a need to revolutionize pharmaceutical packaging towards meeting industry demands through cutting─edge innovations. This is very much required as USD 20 billion counterfeit drug market is posing a big challenge to the
-
Our CEO, Nikhil Chopra, weighs in on key expectations from Budget 2024 🚀 Emphasizing incentives for domestic API manufacturers and strategic PLI measures, JB Pharma aims for a robust, self-sufficient pharmaceutical sector 💼💡 The Economic Times Nikhil Chopra #HealthcareRevolution #Budget2024 #PharmaVisionary
-
-
Senior HR Executive | Driving Operational Excellence & Strategic HR Solutions | Expertise in Talent, Compliance, and Workforce Optimization
In the pharmaceutical industry, R&D is paramount for discovering and developing new drugs, treatments, and therapies, addressing unmet medical needs and improving patient outcomes, while also driving revenue growth and maintaining competitive advantage amidst stringent regulatory standards and evolving healthcare demands. SUN PHARMA being an International pharmaceutical corporation is emphasizing on the pivotal role of R&D in the industry to meet unfulfiled patient demands. RESONACLE #RESONACLE #Pharma #PharmaceuticalIndustry #PharmaBroadcast #news #PharmaNews #NewsUpdates #PharmaNewsupdates #sun #sunpharma #SunPharmaUpdates
#PharmaNews This article in "The Economic Times" goes into further detail on Sun Pharma's strategic plans to grow its specialist business. As an international pharmaceutical corporation, they keep putting more of an emphasis on innovation to launch medications that cater to a range of unmet patient demands. Don't forget to follow RESONACLE for more such updates. #RESONACLE #Pharma #PharmaceuticalIndustry #PharmaBroadcast #news #PharmaNews #NewsUpdates #PharmaNewsupdates #sun #sunpharma #SunPharmaUpdates
-
-
Based on our recent poll, pricing remains the biggest influence in the decision to prescribe a generic drug vs. the original. What do you think about these results — are there other major influences that should be considered? Make sure to follow TriRx Pharmaceutical Services, LLC for more insights into the #pharmaceutical and #animalhealth industries. #lifesciences #cdmo #poll
-
-
Will continuous tableting now develop more dynamically? Exiting project realized by GEA and Hovione for high potent API with the aim of achieving a rapid transition from development to commercial. Interested in your thoughts. Please comment
Hovione announces the opening of its new state-of-the-art continuous tableting (CT) line at the R&D Center in Lisbon. Developed in partnership with GEA Group, this new CT line enhances capacity, flexibility, and efficiency in pharmaceutical manufacturing. It uniquely replicates critical components of Hovione's commercial CT line in Loures and handles highly potent APIs, ensuring optimized operating conditions and smoother transitions from development to commercial scale. This investment highlights Hovione's commitment to innovative solutions that address the evolving needs of the pharmaceutical industry. By offering real-time process data monitoring and flexible throughput, the new CT line supports quicker and more efficient market launches, reinforcing Hovione's global reputation in pharmaceutical manufacturing excellence. Read the full press release: https://lnkd.in/daU4ugWG Learn more about Continuous Tableting for drug product: https://lnkd.in/dhCKNCK2 The future is continuous. #pharmainnovation #continuoustableting #pharmaceuticalmanufacturing #rdcenter #cdmo #initforlife
-
-
Director, Corporate Finance Advisory @ Deloitte | Healthcare and Life sciences, Mergers & Acquisitions
What’s the current state of #biopharma innovation? Explore the latest insights in ‘Unleash AI’s potential’, the 14th edition in our ‘Measuring the return from pharmaceutical innovation’ report series. #LifeSciences #RandD #DeloitteUKLSHC About the report - Our Measuring the return from pharmaceutical innovation series of annual reports has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend
-
#PharmaNews This article in "The Economic Times" goes into further detail on Sun Pharma's strategic plans to grow its specialist business. As an international pharmaceutical corporation, they keep putting more of an emphasis on innovation to launch medications that cater to a range of unmet patient demands. Don't forget to follow RESONACLE for more such updates. #RESONACLE #Pharma #PharmaceuticalIndustry #PharmaBroadcast #news #PharmaNews #NewsUpdates #PharmaNewsupdates #sun #sunpharma #SunPharmaUpdates
-
